IQVIA Holdings Inc. (IQV) News

IQVIA Holdings Inc. (IQV): $216.51

2.71 (+1.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter IQV News Items

IQV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

IQV News Highlights

  • IQV's 30 day story count now stands at 61.
  • Over the past 21 days, the trend for IQV's stories per day has been choppy and unclear. It has oscillated between 1 and 20.
  • The most mentioned tickers in articles about IQV are PRA, AB and NOV.

Latest IQV News From Around the Web

Below are the latest news stories about Iqvia Holdings Inc that investors may wish to consider to help them evaluate IQV as an investment opportunity.

IQVIA Named Top CRO in 2021 WCG CenterWatch Independent Survey

RESEARCH TRIANGLE PARK, N.C., February 24, 2022--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry was named the top CRO in Overall Reputation by clinical trial sites around the world in the 2021 WCG CenterWatch Global Site Relationship Benchmark Survey Report.

Yahoo | February 24, 2022

2 ‘Perfect 10’ Stocks Worth Investing In

Earnings season is coming to an end, with some corporations still to report this week and next. The earnings results so far this reporting cycle have generally been encouraging, and momentum should remain high over the remainder of the reporting period. Despite better-than-expected earnings results, investors have become increasingly anxious as a result of market uncertainty over inflation, political disturbances, rate rises, supply-chain challenges, labor issues, and other factors. In such a market, TipRanks' Smart Score System, which allows investors to do a more thorough analysis of a firm before investing in it, may be beneficial.

Shalu Saraf on TipRanks | February 22, 2022

IQVIA Releases 2021 Environmental, Social, and Governance (ESG) Report

RESEARCH TRIANGLE PARK, N.C., February 22, 2022--IQVIA (NYSE:IQV) today published its 2021 Environmental, Social, and Governance (ESG) Report. The annual report highlights the significant efforts the company has made in advancing healthcare globally, increasing the diversity and engagement of its workforce, and reducing its global environmental footprint.

Yahoo | February 22, 2022

Jefferies Maintains Their Buy Rating on IQVIA Holdings (IQV)

In a report released yesterday, David Windley from Jefferies maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target of $293.00. The company's shares closed last Wednesday at $232.18. According to TipRanks.com, Windley is a top 100 analyst with an average return of 17.1% and a 70.8% success rate. Windley covers the Healthcare sector, focusing on stocks such as UnitedHealth, Catalent, and Humana. The word on The Street in general, suggests a Strong Buy analyst consensus rating for IQVIA Holdings with a $293.09 average price target, representing a 28.3% upside.

Howard Kim on TipRanks | February 17, 2022

IQVIA Holdings – Consensus Indicates Potential 26.8% Upside

IQVIA Holdings with ticker code (IQV) have now 17 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 325 and 255 with the average target price sitting at 289.94. Given that the stocks previous close was at 228.64 this is indicating there is a potential upside of 26.8%. The day 50 moving average is 257.76 and the 200 moving average now moves to 251.16. The company has a market capitalisation of $44,356m. Company Website: https://www.iqvia.com [stock_market_widget type="chart" symbol="IQV" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $56,248m based on the market concensus. IQVIA Holdings Inc. provides advanced analytics, technology solution...

DirectorsTalk | February 17, 2022

Top Analyst Reports for Adobe, Altria Group & Marriott International

Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), Altria Group, Inc. (MO), and Marriott International, Inc. (MAR).

Yahoo | February 17, 2022

IQVIA Holdings (IQV) Received its Third Buy in a Row

After Robert W. Baird and Stifel Nicolaus gave IQVIA Holdings (NYSE: IQV) a Buy rating last month, the company received another Buy, this time from Morgan Stanley. Analyst Tejas Savant maintained a Buy rating on IQVIA Holdings today and set a price target of $280.00. The company's shares closed last Wednesday at $226.32. According to TipRanks.com, Savant is a 1-star analyst with an average return of -5.1% and a 35.4% success rate. Savant covers the Healthcare sector, focusing on stocks such as Nautilus Biotechnolgy, Akoya Biosciences, and Cytek Biosciences. IQVIA Holdings has an analyst consensus of Strong Buy, with a price target consensus of $302.08, implying a 32.

Brian Anderson on TipRanks | February 16, 2022

IQVIA Holdings, Inc. (IQV) Q4 2021 Earnings Call Transcript

IQVIA Holdings, Inc. (NYSE: IQV) Q4 2021 earnings call dated Feb. 15, 2022 Presentation: Operator Ladies and gentlemen, thank you for standing by. At this time, I would like to… […] The post IQVIA Holdings, Inc. (IQV) Q4 2021 Earnings Call Transcript first appeared on AlphaStreet .

AlphaStreet | February 15, 2022

IQVIA Holdings Inc. 2022 Q4 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 15, 2022

IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q4 2021 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 15, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5639 seconds.